This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: B.r.a.h.m.s Gmbh. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Wiesbaden, DE (2014)
- Mainz, DE (2015 - 2016)
Company Filing History:
Years Active: 2014-2016
Title: Innovations and Contributions of Inventor Hans Rupprecht
Introduction
Hans Rupprecht, an accomplished inventor based in Mainz, Germany, has significantly contributed to the field of medical diagnostics with three notable patents. His work primarily focuses on risk stratification in patients suffering from stable coronary artery disease. With a strong background in biomedical research, Rupprecht's inventions are designed to improve patient outcomes and provide innovative solutions in cardiology.
Latest Patents
Among Hans Rupprecht's latest patents is a groundbreaking method for risk stratification in stable coronary artery disease. This in vitro method involves determining the concentration of procalcitonin in patients' circulation using a highly sensitive PCT assay. By establishing cutoff values within the typical normal range of healthy individuals, Rupprecht's invention enables healthcare professionals to distinguish between different risk groups based on individual PCT concentrations. This innovative approach enhances the ability to assess personal cardiac risk for patients with stable arteriosclerosis.
Career Highlights
Throughout his career, Hans Rupprecht has made significant advancements in medical research and diagnostics. His inventive work at B.R.A.H.M.S GmbH showcases his dedication to enhancing healthcare through scientific innovation. With three patents to his name, he continues to play a pivotal role in developing methods that improve patient care in cardiology.
Collaborations
Rupprecht collaborates closely with fellow experts in his field, including Andreas Bergmann and Joachim Struck. These partnerships have fostered an environment of innovation and excellence, allowing for the exchange of ideas that help in the development of state-of-the-art medical solutions. Their collective efforts contribute to advancing scientific knowledge and improving diagnostic methodologies.
Conclusion
Inventor Hans Rupprecht stands out for his impactful contributions to medical diagnostics, particularly in risk stratification for coronary artery disease. His latest patents reflect a commitment to enhancing patient care through innovative solutions. As he continues to work with esteemed colleagues, Rupprecht's future endeavors promise to further advance the field of medicine, underscoring the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile